Embedded Files
About ViroBiome & us
ViroBiome™ develops plant-derived bioactive technologies designed to reinforce biological barriers and support targeted enzymatic modulation within the Augmented Hygiene framework.
Our work is rooted in the understanding that protection begins at the biological interface.
A Platform Approach
ViroBiome™ was built at the intersection of:
• plant bioactive science
• microbiome-compatible design
• host-pathway modulation
• barrier reconstruction research
Our technologies are structured as a modular platform enabling scalable integration into hygiene and barrier-oriented systems.
Augmented Hygiene
Traditional hygiene models focus primarily on elimination.
ViroBiome™ advances a complementary paradigm: Augmented Hygiene.
This approach emphasizes:
• reinforcement rather than disruption
• modulation rather than eradication
• preservation of commensal microbiomes
• compatibility with existing industrial processes
It aligns with the One Health perspective linking human, animal and environmental resilience.
Industrial Orientation
Our patented technologies are engineered for scalable integration into:
• personal and intimate hygiene systems
• barrier-oriented dermal applications
• functional textile treatments
• selected medical-adjacent supports
The objective is to enable next-generation preventive systems without requiring structural modification of manufacturing infrastructures.
Scientific Foundation
ViroBiome™ is supported by multidisciplinary research in:
• plant-derived triterpenes and lipid complexes
• microbiome-compatible formulation science
• enzymatic pathway modulation
• barrier reconstruction mechanisms
Research documentation and intellectual property files are available under confidentiality agreement.
Strategic Vision
We envision protection evolving from elimination-based chemistry toward biologically active interface systems.
From elimination to modulation.
From disruption to resilience.
From isolated protection to integrated health.
Organizational Approach
ViroBiome™ operates through a multidisciplinary model combining:
• bioactive research
• formulation development
• industrial strategy
• cross-sector innovation
We position ourselves at the interface of biotechnology, preventive hygiene and sustainable systems integration.
Our Team
ViroBiome™ is driven by a multidisciplinary team combining:
• scientific research expertise
• formulation and bioactive development
• industrial strategy
• cross-sector innovation
We operate at the intersection of biotechnology, preventive hygiene and sustainable innovation.
Vincent Bourgeteau
Vincent Bourgeteau
Co-founder of Uption SàRL | Co-creator of ViroBiome™ | CEO of Ephyla SAS | Expert in Arboviruses, Bioactives & Industrial Transfer
Vincent Bourgeteau is a trained biologist and former research associate at the Institut Pasteur, specialized in arboviruses and virus–host interactions.
His expertise spans experimental virology, enzymatic pathway modulation involved in viral infectivity, and the translation of fundamental research into scalable industrial applications.
As co-founder of Uption SàRL and co-creator of ViroBiome™, he leads the scientific validation, bioactive characterization, and industrial adaptation of the platform’s technological modules.
He oversees:
• in vitro and ex vivo research models
• enzymatic modulation assessment
• microbiome compatibility evaluation
• formulation optimization
• industrial transfer processes
As CEO of Ephyla SAS, he bridges academic research, applied development and industrial integration.
His work is aligned with the One Health framework, focusing on biologically compatible technologies designed to reinforce biological interfaces without disrupting microbial ecosystems.
Dominique DELARCHE
Co-founder of Uption SàRL | Co-creator of ViroBiome™ | One Health & Bioactive Innovation Expert
Dominique Delarche is an entrepreneur focused on the development of bioactive technologies at the intersection of preventive hygiene, barrier science and industrial scalability.
With a background in strategy, product architecture and cross-sector innovation, he works on structuring platform-based solutions integrating plant-derived bioactives into existing industrial ecosystems.
As co-founder of Uption SàRL, he co-developed ViroBiome™, a modular Augmented Hygiene platform designed to reinforce biological interfaces while preserving microbiome balance.
His work aligns with the One Health framework, connecting human, animal and environmental resilience through biologically compatible technologies.
He collaborates with industrial and research partners across hygiene, biotech, materials science and environmental innovation sectors.
Core focus areas:
• Bioactive platform architecture
• Barrier reinforcement systems
• Enzymatic pathway modulation
• Industrial integration strategy
• Sustainable technology positioning
ViroBiome™ contributes to the transition from elimination-based protection toward biologically augmented resilience systems.
Page updated
Google Sites
Report abuse